Endothelin-1 overexpression in mice increases vascular Vegfa 164 and Vegfa 188 alternative splice isoforms via enhanced Khdrbs3 expression
- 9 June 2026
- journal article
- research article
- Published by Wolters Kluwer Health in Journal Of Hypertension
Abstract
Objectives: Mice with tamoxifen-inducible endothelium-restricted human endothelin-1 (ET-1) overexpression (ieET-1) exhibited blood pressure elevation after 3 weeks and 3 months, and vascular injury after 3 months. We hypothesised that ET-1 overexpression-induced vascular injury is mediated by gene expression dysregulation. Methods: Male ieET-1 mice and mice expressing a tamoxifen-inducible Cre recombinase in endothelial cells were induced with tamoxifen and studied 3-week and 3-month post-treatment. MicroRNA and gene expression were profiled in mesenteric arteries by RNA-sequencing and validated by RT-qPCR. Aorta was used for immunofluorescence microscopy. Results: KH domain containing RNA binding signal transduction associated 3 ( Khdrbs3 ) was the top upregulated gene identified by RNA-sequencing ( P = 8x10 −12 ) validated by RT-qPCR ( P < 0.001) after 3-week and 3-month ET-1 overexpression. KHDRBS3 protein was increased in aortic endothelial and vascular smooth muscle cells (VSMCs) after 3-month ET-1 overexpression. KHDRBS3 is a splicing regulator of various mRNAs, including human vascular endothelial growth factor A ( VEGFA ) 165 isoform with exon 7 retention. Three-month ET-1 overexpression upregulated isoforms Vegfa 164 containing exon 7 and Vegfa 188 retaining exons 6 and 7, and downregulated Vegfa 120 isoform lacking both exons ( P < 0.05). Analysis of RNA-immunoprecipitation-sequencing of myocardium of patients with dilated cardiomyopathy identified VEGFA and four key VSMC-specific pre-mRNAs as KHDRBS3 targets. Reanalysis of RNA-sequencing data of angiotensin II-infused mice revealed a high correlation between ET-1 ( Edn1 ) and Khdrbs3 mRNAs in mesenteric arteries ( r 2 = 0.82, P = 3.7 x 10 −9 ). Conclusion: Endothelial human ET-1 overexpression induced RNA splicing via enhanced Khdrbs3 expression, which may play a role in vascular injury, and could represent a therapeutic target in hypertension.Keywords
This publication has 64 references indexed in Scilit:
- Aquaporins: Important players in the cardiovascular pathophysiologyPharmacological Research, 2022
- SLM2 Is a Novel Cardiac Splicing Factor Involved in Heart Failure due to Dilated CardiomyopathyGenomics, Proteomics & Bioinformatics, 2021
- Human aquaporins: Regulators of transcellular water flowBiochimica et Biophysica Acta (BBA) - General Subjects, 2014
- Extracellular regulation of VEGF: Isoforms, proteolysis, and vascular patterningCytokine & Growth Factor Reviews, 2014
- A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trialThe Lancet, 2009
- Darusentan: An effective endothelinA receptor antagonist for treatment of hypertensionAmerican Journal of Hypertension, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Angiotensin type 1 receptors mediate smooth muscle proliferation and endothelin biosynthesis in rat vascular smooth muscle.The Journal of Pharmacology and Experimental Therapeutics, 1994
- The vascular endothelial growth factor family of polypeptidesJournal of Cellular Biochemistry, 1991
- The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicingJournal of Biological Chemistry, 1991